Insider Stock Trading History of Kuebler Christopher A


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kuebler Christopher A since year 2005. The trader's CIK number is 1229877. At the time of this reporting, Kuebler Christopher A is the Director of Nektar Therapeutics . (stock ticker symbol NKTR). See this page for all insider trading activities at Nektar Therapeutics .

Note that in the past KUEBLER CHRISTOPHER A also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Kuebler Christopher A since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-01-02 NKTR Nektar Therapeutics Option Ex 30,000 14.26 427,800
2018-01-02 NKTR Nektar Therapeutics Sale 30,000 58.66 1,759,800
2017-09-22 NKTR Nektar Therapeutics Sale 4,000 21.86 87,440
2017-08-08 WAT Waters Corp /de/ Option Ex 3,500 76.75 268,625
2017-08-08 WAT Waters Corp /de/ Sale 3,500 179.67 628,845
2017-04-05 NKTR Nektar Therapeutics Sale 15,000 21.88 328,200
2017-04-05 NKTR Nektar Therapeutics Option Ex 15,000 8.37 125,549
2016-09-15 NKTR Nektar Therapeutics Option Ex 15,000 .00 0
2016-09-16 NKTR Nektar Therapeutics Sale 7,500 19.13 143,475
2016-05-04 WAT Waters Corp /de/ Option Ex 4,000 48.88 195,520
2016-05-04 WAT Waters Corp /de/ Sale 4,000 129.88 519,520
2015-12-04 NKTR Nektar Therapeutics Option Ex 15,000 5.15 77,250
2015-12-04 NKTR Nektar Therapeutics Sale 15,000 15.82 237,300
2015-11-23 WAT Waters Corp /de/ Option Ex 4,000 44.25 177,000
2015-11-23 WAT Waters Corp /de/ Sale 4,000 133.17 532,680
2015-01-13 NKTR Nektar Therapeutics Option Ex 15,000 8.81 132,150
2015-01-13 NKTR Nektar Therapeutics Sale 15,000 16.00 240,000
2013-08-05 NKTR Nektar Therapeutics Sale 12,500 12.41 155,125
2013-08-05 NKTR Nektar Therapeutics Option Ex 12,500 11.41 142,625
2012-09-27 NKTR Nektar Therapeutics Option Ex 12,500 8.66 108,250
2012-09-27 NKTR Nektar Therapeutics Sale 12,500 10.66 133,250
2011-03-07 NKTR Nektar Therapeutics Option Ex 10,000 .00 0
2008-11-14 NKTR Nektar Therapeutics Option Ex 5,000 .00 0
2005-03-21 CVD Covance Inc Sale 17,271 45.23 781,184

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kuebler Christopher A (Director of Nektar Therapeutics at the time of this reporting) see the Securities and Exchange Commission (SEC) website.